Total Hip Arthroplasty Using Small Direct Anterior Incision: The Role of Short Femoral Stem
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01614028
Verified April 2013 by Rothman Institute Orthopaedics. Recruitment status was: Recruiting
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patient signed an IRB, study specific informed patient consent.
Patient is a male or non-pregnant female age 18 years or older at the time of study device implantation.
Patient has primary diagnosis of non-inflammatory degenerative joint disease.
Patient is a candidate for primary cementless total hip replacement.
Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.
Patient has a Body Mass Index (BMI) > 40 Kg/m2.
Patient has an active or suspected infection at the time of device implantation.
Patient is immunologically suppressed.
Patient requires revision surgery of a previously implanted total hip replacement.
Patient has a known sensitivity to device materials.